Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-037167

Options or other derivatives

  • Director acquired 2,924 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Talukdar Lavina · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-02 Grant or award : show line 1 in the form Stock Options +2,924 2,924 D
Loading xslF345X05/rdgdoc.xml…